Does Mounjaro Wear Off After 5 Days — and Should You Be Worried?

What does a five-day half-life actually mean for your appetite?

Half-life is a pharmacokinetic term: it describes how long it takes for the concentration of a drug in your bloodstream to fall by fifty percent. For tirzepatide, that figure is roughly five days. So on day five after your injection, you still have about half the peak concentration active. On day seven, when your next dose is due, you have somewhere around forty percent or so remaining. The medicine does not hit zero and switch off, it tapers.

What this means practically is that the appetite suppression, nausea, and fullness signals tirzepatide produces do fade gradually as the week goes on. Many people find the first three or four days after an injection feel noticeably different from days six and seven. Hunger edges back, portions feel less self-limiting, and food becomes more appealing. If you have noticed that Mounjaro seems to wear off after around five days, this is the expected pharmacological behaviour of a once-weekly drug with this particular half-life, not a sign of tolerance developing, and not the medicine wearing off in any broken sense.

A quick check you can do yourself: note your appetite on a simple 1–10 scale each morning for two weeks. Most people see a clear weekly rhythm that mirrors the injection day, which confirms the medicine is behaving as expected rather than losing effect.

If you want to understand more about how tirzepatide works at a receptor level, our Mounjaro overview page explains the dual GIP and GLP-1 mechanism in plain terms.

Is end-of-week hunger a problem that needs fixing?

Not necessarily. The return of some appetite before the next injection is built into the pharmacology, and clinical trial participants experienced exactly this pattern. In SURMOUNT-1, published in the New England Journal of Medicine, participants using tirzepatide at maintenance doses achieved an average body-weight reduction of around 20–21% at 72 weeks, a result achieved within a once-weekly dosing schedule that includes exactly these end-of-week troughs.

The question worth asking is how pronounced the effect is. A mild increase in hunger on days six and seven is normal. Feeling as though the medicine has entirely stopped working, or experiencing significant distress from hunger returning, is worth raising with your prescriber. They may consider whether a dose adjustment is appropriate, or whether other factors (sleep, stress, a recent illness) are amplifying the trough.

Two things people sometimes do that are worth avoiding: injecting a day early to smooth out the trough (this changes the dosing interval and is not what the prescriber approved), or skipping a dose because the trough convinced them the medicine was not working. Both decisions belong to your prescriber, not to a solo judgment call mid-cycle. The detailed look at when Mounjaro's effects ease across the week covers this timing question further.

Could the medicine genuinely be losing effect over time?

This is a different question from the five-day half-life point, and it matters. Some people do find that after several months on a given dose, weight loss slows or appetite suppression feels less robust. This can happen for a few reasons: the body adapts, starting weight falls (so the absolute calorie deficit changes), or lifestyle factors shift. It is not the same as the weekly trough, which is predictable and pharmacokinetic.

If you are seeing a sustained plateau or feel consistently less covered across the whole week rather than just days six and seven, that is a signal to raise with your prescriber. The licensed titration schedule exists precisely for this situation, moving to a higher dose under clinical supervision can restore effect for many people. Our piece on tirzepatide and body composition looks at how the medicine's effects on fat and muscle change across a longer treatment course, which is useful context here.

For private treatment, a prescriber reviews your progress before every repeat supply, so there is a structured opportunity to flag this at each order, rather than waiting for a routine GP appointment.

What should you actually do if the five-day trough bothers you?

Start by ruling out the ordinary: a poor night's sleep, a stressful week, or eating fewer calories than usual can all make hunger feel sharper on days six and seven. Protein intake and hydration also affect how well appetite stays regulated toward the end of the week. If those boxes are ticked and the trough is still disrupting daily life, speak to your prescriber.

What a prescriber can offer here is a clinical view of whether the trough severity matches what would be expected at your current dose and stage of treatment, whether a dose increase is appropriate and timely under your titration schedule, and whether anything in your history makes the pattern unusual. They cannot (and should not) be bypassed.

A practical note on cost: if you are finding the weekly cycle difficult, it is worth knowing what is included in the price you are paying. Some providers charge separately for dose-review consultations. Our Mounjaro pricing page explains what is covered at each stage with nume. If you have broader questions about treatment, the FAQ page covers common concerns in one place. When you are ready to speak to a prescriber, starting a free consultation is the first step.